The Immune Pathogenesis of Immune Reconstitution Inflammatory Syndrome Associated with Highly Active Antiretroviral Therapy in AIDS

Abstract

The present study investigated the immunological pathogenesis of immune reconstitution inflammatory syndrome (IRIS) in acquired immunodeficiency syndrome (AIDS) patients undergoing highly active antiretroviral therapy (HAART). A total of 238 patients with AIDS who received initial HAART were included in this prospective cohort study. Blood samples were collected immediately, at baseline, at week 12, and at week 24 after initial HAART and at the onset of IRIS. Lymphocyte subsets, Th1 and Th2 cytokines, and interleukin (IL)-7 levels were measured by flow cytometry or ELISA. Among the 238 patients with AIDS who received HAART, 47 patients developed IRIS. The percentages of CD4⁺ and CD8⁺ naive, memory, and activated cells exhibited no significant differences between AIDS patients with and without IRIS 24 weeks after initial HAART. The percentage of CD4⁺CD25⁺Foxp3⁺ regulatory T cells was lower in IRIS patients than in non-IRIS patients before HAART, 12 weeks after HAART, 24 weeks after HAART, and at the onset of IRIS. IL-2 and interferon (IFN)-γ levels were significantly higher at week 4 and at the onset of IRIS in IRIS patients than in non-IRIS patients. In contrast, IL-4 and IL-10 levels were significantly lower at week 4 and at the onset of IRIS in IRIS patients than in non-IRIS patients. Plasma IL-7 decreased gradually with the progression of HAART. The level of IL-7 was higher in IRIS patients than in non-IRIS patients at all follow-up time points. An imbalance of Th1/Th2 cytokines, a consistently low CD⁺CD25⁺Fox3⁺ percentage, and a high IL-7 level may be crucial in the pathogenesis of IRIS in AIDS patients who had received HAART.

Get full access to this article

View all access options for this article.

References

, Zheng

, Chen

, et al.: Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients. Zhonghua Yi Xue Za Zhi, 2007; 87:2973–2976.

Zhou

, Zheng

, He

, et al.: Evaluation of a 6-year highly active antiretroviral therapy in Chinese HIV-1 infected patients. Intervirology, 2010; 53:240–246.

Liu

, Zheng

, Zhou

, et al.: Study on the effects of G2 arrest and apoptosis in Jurkat cells by HIV-1 Vpr. Chin J Microbiol Immunol, 2009; 20:1025–1030.

Zhou

and Zheng

: Antiretroviral therapy and immune reconstitution inflammatory syndrome. Chin J Infect Control, 2009; 8:368–372.

Glencross

, Janossy

, Coetzee

, et al.: CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: Findings from the first year of the CIPRA-SA cohort. Cytometry B Clin Cytom, 2008; 74(Suppl 1):S131–140.

International Network for the Study of HIV-associated IRIS (INSHI). www.inshi.umn.edu/definitions/General_IRIS/home.html.

, Li

, Zheng

, et al.: A randomized case-control study of dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients. AIDS Res Hum Retroviruses, 2012; 28:339–345.

and Zheng

: Clinical analysis and curative effect of opportunity infection in 100 AIDS patients. Chin J Infect Control, 2007; 6:311–315.

Ochs

, Ziegler

, and Torgerson

: FOXP3 acts as a rheostat of the immune response. Immunol Rev, 2005; 203:156–164.

10.

Apoil

, Puissant

, Roubinet

, et al.: FOXP3 mRNA levels are decreased in peripheral blood CD4+lymphocytes from HIV-positive patients. J Acquir Immune Defic Syndr, 2005; 39:381–385.

11.

Seddiki

and Kelleher

: Regulatory T cells in HIV infection: Who's suppressing what?. Curr HIV/AIDS Rep, 2008; 5:20–26.

12.

Cianchetta-Sivori

, Raso

, Fernandez-Guerrero

, et al.: Do CD8(+)CD25(+) cells predict immune reconstitution syndrome in HIV-positive patients who begin HAART?. AIDS, 2007; 21:2347–2349.

13.

Lim

, D'Orsogna

, Price

, et al.: Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease. AIDS Res Ther, 2008; 5:9.

14.

Antonelli

, Mahnke

, Hodge

, et al.: Elevated frequencies of highly activated CD4+T cells in HIV+patients developing immune reconstitution inflammatory syndrome. Blood, 2010; 116:3818–3827.

15.

Seddiki

, Sasson

, Santner-Nanan

, et al.: Proliferation of weakly suppressive regulatory CD4+T cells is associated with over-active CD4+T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol, 2009:39:391–403.

16.

Murdoch

, Venter

, Van Rie

, et al.: Immune reconstitution inflammatory syndrome (IRIS): Review of common infectious manifestations and treatment options. AIDS Res Ther, 2007; 4:9.

17.

Rallón

, López

, Lozano

, et al.: Longitudinal assessment of interleukin 7 plasma levels in HIV-infected patients in the absence of and under antiretroviral therapy. J Acquir Immune Defic Syndr, 2011; 58:436–441.

18.

Fry

and Mackall

: Interleukin-7 and immunorestoration in HIV: Beyond the thymus. J Hematother Stem Cell Res, 2002; 11:803–807.

19.

Fry

, Moniuszko

, Creekmore

, et al.: IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood, 2003; 101:2294–2299.

20.

French

: HIV/AIDS: Immune reconstitution inflammatory syndrome: A reappraisal. Clin Infect Dis, 2009; 48:101–107.

21.

Zhou

, Zheng

, Zhang

, et al.: A one-year clinical trial using didanosine, stavudine and nevirapine for highly active antiretroviral therapy. Chinese Med J, 2005; 118; 609–611.

22.

Saag

: The impact of highly active antiretroviral therapy on HIV-specific immune function. AIDS, 2001; 15(Suppl 2):S4–10.

23.

Zheng

, Chen

, Lei

, et al.: Immunological changes in HIV-1 infected patients treated with highly active antiretroviral therapy. Clin J Dermatol, 2006; 39:281–284.

24.

Dhasmana

, Dheda

, Ravn

, et al.: Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: Pathogenesis, clinical manifestations and management. Drugs, 2008; 68:191–208.

25.

Phillips

, Bonner

, Gataric

, et al.: Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: Spectrum of disease and long-term follow-up. Clin Infect Dis, 2005; 41:1483–1497.